en
Feedback
Respiratory Updates

Respiratory Updates

Open in Telegram

🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Show more

📈 Analytical overview of Telegram channel Respiratory Updates

Channel Respiratory Updates (@respiratoryupdates) in the English language segment is an active participant. Currently, the community unites 19 779 subscribers, ranking 1 151 in the Medicine category and 16 980 in the Iran region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 19 779 subscribers.

According to the latest data from 17 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 506 over the last 30 days and by 26 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 21.91%. Within the first 24 hours after publication, content typically collects 5.17% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 4 333 views. Within the first day, a publication typically gains 1 022 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 11.
  • Thematic interests: Content is focused on key topics such as patient, guideline, edit, reader, society.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
🟢 To stay up-to-date on pharmacotherapy and other aspects of respiratory diseases🫁 🟢 Thoracic Research Center🔬 🟢 Tehran University of Medical Sciences🎓

Thanks to the high frequency of updates (latest data received on 18 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

19 779
Subscribers
+2624 hours
+1437 days
+50630 days
Posts Archive
Repost from N/a
+1
Staphylococcus aureus Skin and Soft Tissue Infections _ Infect Dis Clin N Am 2026

Repost from N/a
photo content

Repost from N/a
photo content

Repost from N/a
photo content

Repost from N/a
photo content

Cystic Fibrosis
Cystic Fibrosis

Repost from N/a
Vasopressor weaning in septic shock: Why the field has been asking the wrong question _ Journal of Critical Care Aug26

+1
🔴 Direct Oral Anticoagulants in Primary and Secondary Prevention of Thrombotic Events: 2026 ACC Scientific Statement

IDSA_Treatment_of_Antimicrobial_Resistant_Gram_Negative_Infections.pdf1.15 MB

Repost from Pulmonology pearls
SARCOIDOSIS: Edited by Vasileios Kouranos and Maneesh Bhargava Recent updates in advanced pulmonary sarcoidosis Current Opinion in Pulmonary Medicine 32(5):p 491-499, September 2026. | DOI: 10.1097/MCP.0000000000001295

Repost from Pulmonology pearls
Respiratory Medicine Volume 255, April–May 2026, 108751 Original Research The effect of the CareAide® mobile application in adult outpatients with asthma: A randomised controlled trial https://doi.org/10.1016/j.rmed.2026.108751

Repost from Pulmonology pearls
Navigating evidence-based recommendations for the management of systemic sclerosis. Nat Rev Rheumatol (2026). https://doi.org/10.1038/s41584-026-01416-z

Repost from Pulmonology pearls
Review Article Nebulized Heparin in Adults With Acute Respiratory Failure: A Meta-Analysis of Randomized Trials the Nebulized Heparin Study Group Critical Care Medicine 54(7):p 1755-1766, July 2026. | DOI: 10.1097/CCM.0000000000007161

Annals of intensive care.pdf1.02 MB

Repost from Pulmonology pearls
American Journal of Kidney Diseases Available online 3 July 2026 In Press, Journal Pre-proof Perspective Approach to Hyperkalemia: The Role of Diet and Pharmacological Therapies https://doi.org/10.1053/j.ajkd.2026.03.048

ICU Nutrition Q&A.pdf5.85 KB

Repost from N/a
خلاصه وازوپرسو و اینوتروپ #Critical_Care
خلاصه وازوپرسو و اینوتروپ #Critical_Care

Repost from N/a
آقای ۶۲ ساله با تشخیص شوک سپتیک ناشی از پنومونی، در icu . بیمار تحت رژیم درمانی با نوراپی‌نفرین ۳۶ میکروگرم در دقیقه قرار دارد. در آخرین بررسی: · MAP = ۵۵ U/O = ۰.۳ cc/kh/ht · لاکتات سرم = ۴.۲ (روند نزولی ندارد) · CRT = ۴ بهترین اقدام؟
Anonymous voting

Repost from Pulmonology pearls
Feature Article Inhaled Antibiotics to Treat Ventilator-Associated Pneumonia: A Systematic Review and Meta-Analysis Critical Care Medicine 54(6):p 1293-1308, June 2026. | DOI: 10.1097/CCM.0000000000007072

Repost from Pulmonology pearls
+2
The Lancet Respiratory Medicine Available online 5 June 2026 In Press, Corrected Proof Position Paper Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement https://doi.org/10.1016/S2213-2600(26)00094-9